The Chinese STEMI PPCI Registry (CSPR)
- Conditions
- ST-segment Elevation Myocardial Infarction (STEMI)
- Registration Number
- NCT04996901
- Lead Sponsor
- Renmin Hospital of Wuhan University
- Brief Summary
The purpose of this study is to develop a risk score to predict the risks of in-hospital major adverse cardiac events in ST-segment elevation myocardial infarction patients treated by primary percutaneous coronary intervention.
- Detailed Description
The CSPR trial is an observational clinical trial to derive and validate a readily useable risk score to identify patients at high risk of in-hospital major adverse cardiac events in 5594 patients presenting with a ST-segment elevation myocardial infarction and treated by primary percutaneous coronary intervention.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 5594
- Age≥18
- ST-segment elevation myocardial infarction was defined according to the universal definition of myocardial infarction
- STEMI treated by pPCI
- Patient with heart failure in admission
- STEMI with symptom-onset-to-balloon time>24h
- pPCI was not successful or only underwent coronary angiography
- Killip class ≥II in admission
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method in-hospital acute de novo heart failure in-hospital outcome, until discharge Killip class ≥II
cardiogenic shock in-hospital outcome, until discharge according to the universal definition
death in-hospital outcome, until discharge according to the universal definition
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Renmin Hospital of Wuhan university
🇨🇳Wuhan, Hubei, China
Renmin Hospital of Wuhan university🇨🇳Wuhan, Hubei, China